HF 14 (LSB 1725YH (3) 91)

HOUSE FILE 14

BY  A. MEYER

A BILL FOR

An Act relating to the controlled substance crystalline polymorph psilocybin.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:

    Section 1.  Section 124.201, Code 2025, is amended by adding the following new subsection:
   NEW SUBSECTION.  5.  a.  Notwithstanding section 124.204, subsection 4, a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin, also known as COMP 360, or any other trade name approved by the United States food and drug administration, shall be immediately removed from schedule I under section 124.204, subsection 4, paragraph “s”, upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act, 21 U.S.C. §812, and 21 C.F.R. §1308.14.
   b.  Immediately upon the rescheduling of the drug under paragraph “a”, it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin, also known as COMP 360, or any other trade name approved by the United States food and drug administration.
EXPLANATION
The inclusion of this explanation does not constitute agreement with
the explanation’s substance by the members of the general assembly.
   This bill relates to the controlled substance crystalline polymorph psilocybin.
   Current law categorizes the controlled substance psilocybin as a schedule I, hallucinogenic substance (Code section 124.201(4)(s)).
   The bill provides that notwithstanding Code section 124.204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act.
   The bill provides that upon the rescheduling of psilocybin, it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin.
   Current penalties for the possession of psilocybin range from a serious misdemeanor to a class “B” felony.